Episode Details

MustGrow Biologics (TSXV: MGRO | OTCQB: MGROF) has reached an important milestone in its relationship with Bayer, receiving its first development milestone payment tied to the advancement of TerraMG™. In this episode, COO Colin Bletsky discusses what the payment signals about the technology and partnership, while outlining the potential strategic value of Bayer's development, regulatory and commercialization capabilities across Europe, the Middle East and Africa.

Listeners will hear about:

• MustGrow's first development milestone payment from Bayer
• The progress of TerraMG™ toward potential commercialization
• Bayer's role in development, registration and market access
• The potential for expansion into additional markets
• MustGrow's broader biological agriculture platform and global growth strategy

This podcast is made in partnership with MustGrow Biologics. This podcast is for informational purposes only. Please do your own due diligence. For our full disclaimer, visit: https://stockhouse.com/legal/disclaimer

#MustGrow #Bayer #AgTech #BiologicalAgriculture #RegenerativeAgriculture #Investing #MGRO

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.